Ronald Rogers

发表

HPV Chemical Tests Threaten Small Producers: High costs of testing high-production-volume chemicals worry smaller firms

Ronald Rogers, R. Rogers, 1999 .

INFORMEX OR E–FORMEX?: Fine chemicals exposition serves as a barometer for dealmaking and trends in the chemical industry

Ronald Rogers, 2000 .

Companies Turn To Biocatalysis: Drive to meet customer demands for single-isomer intermediates takes on urgency

Ronald Rogers, 1999 .

BATTLING FOR BLOCKBUSTERS: Drug firms are projected to gain more revenue from licensed compounds than from those discovered internally

Ronald Rogers, 1999 .

PRICKLY RESEARCH PARTNERSHIPS: Universities welcome industry support of research, but cultural differences, issues of intellectual property create problems

Ronald Rogers, 1998 .

BIOINFORMATICS BEGINS TO BUZZ

Ronald Rogers, 1998 .

AGGRESSIVE ELAN'S METEORIC RISE: Irish firm is a model for how midsized drug companies can take advantage of acquisition opportunities

Ronald Rogers, 2000 .

entrepreneurs: Parelec: Charged up and ready to serve electronic circuit board makers

Ronald Rogers, 1999 .

Membrane materials market to grow steadily

Ronald Rogers, 1998 .

Copromotions add value to pharmaceutical products

Ronald Rogers, 1999 .

Y2K: PREPARE OR BEWARE: With 81 days left until 2000, are U.S.'s small chemical firms ready?

Ronald Rogers, 1999 .

OXFORD ASYMMETRY FINDS NICHE MARKET: British company capitalizes on trend among life sciences firms to outsource chemical services

Ronald Rogers, 1999 .

JOB CUTS TAKE HUMAN TOLL

Ronald Rogers, 1999 .

Private-Equity Investors Increase Stake In Chemicals

Ronald Rogers, 1999 .

MSI Combines Computers With Chemistry: Molecular Simulations Inc. modifies its business and marketing strategies after merging with Pharmacopeia

Ronald Rogers, 1999 .